Scarlet Fever Treatment
Treat scarlet fever immediately with penicillin antibiotics for 10 days, regardless of severity, to prevent serious complications including rheumatic fever and glomerulonephritis.
First-Line Treatment
Penicillin V (phenoxymethylpenicillin) is the drug of choice for scarlet fever, which is caused by toxin-producing Streptococcus pyogenes (Group A Streptococcus) 1, 2, 3. The rationale for immediate antibiotic treatment differs from other mild infections—even though scarlet fever may appear mild, antibiotics are essential to:
- Speed recovery and reduce symptom duration
- Shorten the contagious period
- Prevent life-threatening complications including acute rheumatic fever, endocarditis, and glomerulonephritis 4, 5
Dosing Regimens
For oral therapy (preferred):
- Penicillin V: Standard dosing for 10 days 1
- Adults: 250-500 mg every 6 hours
- Children: Weight-based dosing
For intramuscular therapy (when adherence is uncertain):
- Benzathine penicillin G: Single injection 1
- Preferred when patients are unlikely to complete a full 10-day oral course
Penicillin-Allergic Patients
For patients with penicillin allergy:
- First-generation cephalosporins (if no type 1 hypersensitivity/anaphylaxis) 1
- Macrolides: Erythromycin or clarithromycin 1
- Clindamycin: Alternative option 3
Critical caveat: Do NOT use cephalosporins in patients with immediate hypersensitivity reactions (anaphylaxis or hives) to β-lactam antibiotics 1.
Clinical Recognition
Scarlet fever presents with a distinctive triad that dental and medical professionals should recognize immediately 4, 2:
- Sandpaper-like rash: Maculopapular, typically starting on trunk
- High fever (>38°C)
- Sore throat with pharyngitis
Oral manifestations (often first noted by dentists):
- "Strawberry tongue" or "raspberry tongue" with prominent fungiform papillae 4
- Erythematous oral mucosa
- These oral findings are pathognomonic and warrant immediate referral
Treatment Duration and Monitoring
Complete the full 10-day course even if symptoms resolve earlier 1. This duration is critical for:
- Eradicating the organism from the pharynx
- Preventing rheumatic fever (which can occur even after treated infections) 6
- Reducing transmission to contacts
Response to Treatment
Expected response 7:
- Fever should resolve within 24-48 hours
- Approximately 77% respond to oral penicillin
- If no improvement after 48 hours, consider treatment failure or complications
Non-responders: If fever persists beyond 48 hours or symptoms worsen, reassess for:
- Complications (peritonsillar abscess, cervical lymphadenitis)
- Alternative diagnosis
- Antibiotic resistance (rare but emerging)
Contact Management
Do NOT routinely culture or treat asymptomatic household contacts 1. However, treat symptomatic contacts promptly, especially:
- Family members with sore throat or fever
- Close contacts in outbreak settings (schools, daycare centers)
Exception: During documented outbreaks in institutional settings, culture all exposed individuals and treat those who are positive 1.
Prevention of Long-Term Sequelae
Patients who develop acute rheumatic fever require long-term prophylaxis 6:
- With carditis and residual heart disease: 10 years or until age 40 (whichever is longer), potentially lifelong
- With carditis but no residual disease: 10 years or until age 21
- Without carditis: 5 years or until age 21
This continuous prophylaxis (typically monthly benzathine penicillin G injections) is essential because recurrent GAS infections—even asymptomatic ones—can trigger devastating rheumatic fever recurrences 6.
Current Epidemiological Context
Be aware of the recent resurgence: England experienced a 3-fold increase in scarlet fever incidence between 2013-2014, reaching the highest rates in 50 years 8. Similar increases have been reported in China and the UAE 7, 9. The post-COVID-19 period has seen further increases in Europe 4. This resurgence makes clinical vigilance particularly important, as many practitioners may be unfamiliar with this once-rare disease.
- Children aged 3-7 years (peak incidence at age 6)
- Males affected 1.5 times more than females
- Kindergarten and primary school settings are transmission hotspots